Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$187.26 - $240.17 $76,589 - $98,229
-409 Reduced 23.0%
1,369 $328,000
Q1 2023

May 03, 2023

SELL
$174.31 - $239.52 $343,042 - $471,375
-1,968 Reduced 52.54%
1,778 $334,000
Q4 2022

Feb 08, 2023

SELL
$153.06 - $226.57 $146,937 - $217,507
-960 Reduced 20.4%
3,746 $796,000
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $21,769 - $27,373
-150 Reduced 3.09%
4,706 $740,000
Q2 2022

Sep 06, 2022

BUY
$130.2 - $168.03 $291,648 - $376,387
2,240 Added 85.63%
4,856 $727,000
Q1 2022

May 25, 2022

SELL
$138.87 - $214.31 $124,566 - $192,236
-897 Reduced 25.53%
2,616 $428,000
Q4 2021

Feb 11, 2022

SELL
$182.74 - $227.9 $1.04 Million - $1.3 Million
-5,705 Reduced 61.89%
3,513 $765,000
Q3 2021

Nov 12, 2021

SELL
$170.18 - $198.21 $166,946 - $194,444
-981 Reduced 9.62%
9,218 $1.75 Million
Q1 2021

May 06, 2021

SELL
$132.02 - $168.26 $154,727 - $197,200
-1,172 Reduced 10.31%
10,199 $1.67 Million
Q4 2020

Feb 18, 2021

SELL
$109.38 - $149.19 $25,048 - $34,164
-229 Reduced 1.97%
11,371 $1.58 Million
Q3 2020

Nov 06, 2020

SELL
$92.95 - $130.61 $6,413 - $9,012
-69 Reduced 0.59%
11,600 $1.3 Million
Q2 2020

Aug 05, 2020

SELL
$68.08 - $95.68 $3,540 - $4,975
-52 Reduced 0.44%
11,669 $1.09 Million
Q1 2020

Apr 29, 2020

BUY
$61.71 - $101.95 $6,911 - $11,418
112 Added 0.96%
11,721 $860,000
Q4 2019

Jan 17, 2020

BUY
$70.08 - $84.64 $22,005 - $26,576
314 Added 2.78%
11,609 $976,000
Q3 2019

Nov 04, 2019

SELL
$62.38 - $85.89 $56,142 - $77,301
-900 Reduced 7.38%
11,295 $949,000
Q2 2019

Jul 10, 2019

BUY
$53.64 - $65.42 $654,139 - $797,796
12,195 New
12,195 $798,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $11.2B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track First National Bank Of Omaha Portfolio

Follow First National Bank Of Omaha and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of Omaha, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of Omaha with notifications on news.